$VUZI
Vuzix Corp Stock $vuzi

$vuzi Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000155837022002641 Filed on March 02, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021 Q2
Revenue	$3.314M	$3.019M	$2.917M
YoY Change	-21.71%	8.64%	-3.95%
Cost Of Revenue	$3.106M	$2.435M	$2.337M
YoY Change	-12.02%	0.19%	4.29%
Gross Profit	$209.0K	$583.0K	$579.0K
YoY Change	-70.27%	67.53%	-27.26%
Gross Profit Margin	6.31%	19.31%	19.85%
Selling, General & Admin	$12.89M	$4.702M	$6.087M
YoY Change	315.74%	82.85%	134.42%
% of Gross Profit	6166.54%	806.46%	1051.38%
Research & Development	$3.624M	$3.270M	$2.701M
YoY Change	93.8%	74.48%	50.35%
% of Gross Profit	1733.99%	560.94%	466.45%
Depreciation & Amortization	$675.9K	$494.4K	$559.3K
YoY Change	16.53%	-27.3%	-20.1%
% of Gross Profit	323.4%	84.8%	96.6%
Operating Expenses	$16.93M	$8.414M	$9.321M
YoY Change	207.25%	65.1%	85.16%
Operating Profit	-$16.72M	-$7.830M	-$8.741M
YoY Change	247.83%	64.91%	106.27%
Interest Expense	-$8.450K	-$10.16K	-$25.39K
YoY Change	-71.83%		-353.9%
% of Operating Profit
Other Income/Expense, Net	-$169.3K	-$115.7K	-$38.18K
YoY Change	182.22%	819.16%	4720.2%
Pretax Income	-$17.01M	-$7.946M	-$8.779M
YoY Change	373.88%	66.91%	107.13%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$11.49M	-$10.49M	-$9.245M
YoY Change	220.17%	120.27%	118.09%
Net Earnings / Revenue	-346.83%	-347.37%	-316.94%
Basic Earnings Per Share	-$0.17	-$0.17	-$0.15
Diluted Earnings Per Share	-$0.13	-$0.13	-$0.14
COMMON SHARES
Basic Shares Outstanding	63.63M	63.58M	63.07M
Diluted Shares Outstanding		63.52M

Balance Sheet

Concept	2021 Q4	2021 Q3	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$120.2M	$128.7M	$137.6M
YoY Change	232.97%	417.05%	942.46%
Cash & Equivalents	$120.2M	$128.7M	$137.6M
Short-Term Investments
Other Short-Term Assets	$2.552M	$4.302M	$4.447M
YoY Change	70.12%	168.89%	122.35%
Inventory	$12.15M	$9.880M	$7.884M
Prepaid Expenses
Receivables	$2.242M	$1.059M	$1.099M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$137.2M	$144.0M	$151.0M
YoY Change	204.4%	320.8%	558.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.190M	$5.339M	$2.902M
YoY Change	82.93%	65.97%	-17.13%
Goodwill
YoY Change
Intangibles	$1.988M	$1.862M	$1.678M
YoY Change	24.82%	28.15%	22.45%
Long-Term Investments
YoY Change
Other Assets	$1.484M	$1.357M	$825.0K
YoY Change	109.45%	108.7%	50.0%
Total Long-Term Assets	$11.32M	$11.48M	$8.674M
YoY Change	52.6%	46.46%	6.05%
TOTAL ASSETS
Total Short-Term Assets	$137.2M	$144.0M	$151.0M
Total Long-Term Assets	$11.32M	$11.48M	$8.674M
Total Assets	$148.5M	$155.5M	$159.7M
YoY Change	182.95%	269.68%	413.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.055M	$1.483M	$1.425M
YoY Change	35.44%	63.11%	71.15%
Accrued Expenses	$1.419M	$1.585M	$1.058M
YoY Change	44.38%	81.37%	38.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.156M	$3.650M	$3.129M
YoY Change	34.27%	12.05%	11.19%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$582.9K	$687.6K	$837.3K
YoY Change	-47.01%	-42.7%	-35.59%
Total Long-Term Liabilities	$582.9K	$687.6K	$837.3K
YoY Change	-47.01%	12.55%	-3.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.156M	$3.650M	$3.129M
Total Long-Term Liabilities	$582.9K	$687.6K	$837.3K
Total Liabilities	$4.739M	$4.338M	$3.966M
YoY Change	13.69%	-14.04%	-20.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$203.1M	-$186.1M	-$178.1M
YoY Change	24.82%	16.94%	15.4%
Common Stock	$63.67K	$63.63K	$63.28K
YoY Change	39.49%	48.96%	62.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	$0.00
Shareholders Equity	$143.7M	$151.1M	$155.7M
YoY Change
Total Liabilities & Shareholders Equity	$148.5M	$155.5M	$159.7M
YoY Change	182.95%	269.68%	413.5%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021 Q2
OPERATING ACTIVITIES
Net Income	-$11.49M	-$10.49M	-$9.245M
YoY Change	220.17%	120.27%	118.09%
Depreciation, Depletion And Amortization	$675.9K	$494.4K	$559.3K
YoY Change	16.53%	-27.3%	-20.1%
Cash From Operating Activities	-$8.071M	-$5.801M	-$7.189M
YoY Change	198.93%	142.71%	53.93%
INVESTING ACTIVITIES
Capital Expenditures	-$512.0K	-$3.102M	-$588.8K
YoY Change	55.15%	496.48%	54.94%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$512.0K	-$3.102M	-$588.8K
YoY Change	55.15%	496.48%	54.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	40.21K	44.71K	12.66M
YoY Change	-99.72%	-99.69%	4.3%
NET CHANGE
Cash From Operating Activities	-8.071M	-5.801M	-7.189M
Cash From Investing Activities	-512.0K	-3.102M	-588.8K
Cash From Financing Activities	40.21K	44.71K	12.66M
Net Change In Cash	-8.543M	-8.858M	4.885M
YoY Change	-176.82%	-175.64%	-31.1%
FREE CASH FLOW
Cash From Operating Activities	-$8.071M	-$5.801M	-$7.189M
Capital Expenditures	-$512.0K	-$3.102M	-$588.8K
Free Cash Flow	-$7.559M	-$2.699M	-$6.600M
YoY Change	218.94%	44.33%	53.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61125215
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38109765
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001463972
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30348452
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	49626
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45645166
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63672268
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63672268
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45645166
CY2021	vuzi	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2021	vuzi	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-35955
CY2021	dei	Entity Registrant Name EntityRegistrantName	Vuzix Corp
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3392453
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	25 Hendrix Road
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	West Henrietta
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14586
CY2021	dei	City Area Code CityAreaCode	585
CY2021	dei	Local Phone Number LocalPhoneNumber	359-5900
CY2021	dei	Security12b Title Security12bTitle	Common Stock
CY2021	dei	Trading Symbol TradingSymbol	VUZI
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q4	us-gaap	Assets Current AssetsCurrent	45055251
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5190438
CY2020Q4	vuzi	Finite Lived License Agreements Current FiniteLivedLicenseAgreementsCurrent	272444
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1082000000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	63672268
CY2021	dei	Auditor Firm AuditorFirmId	317
CY2021	dei	Auditor Name AuditorName	Freed Maxick CPAs, P.C.
CY2021	dei	Auditor Location AuditorLocation	Buffalo, New York
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120203873
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36069508
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2242429
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1388882
CY2021Q4	us-gaap	Inventory Net InventoryNet	12151982
CY2020Q4	us-gaap	Inventory Net InventoryNet	6100824
CY2021Q4	vuzi	Prepaid Manufacturing Vendor Payments PrepaidManufacturingVendorPayments	504051
CY2020Q4	vuzi	Prepaid Manufacturing Vendor Payments PrepaidManufacturingVendorPayments	485032
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2047819
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	738561
CY2021Q4	us-gaap	Assets Current AssetsCurrent	137150154
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2837402
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1117022
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1517306
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1988370
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1593049
CY2021Q4	vuzi	Finite Lived License Agreements Noncurrent FiniteLivedLicenseAgreementsNoncurrent	1389936
CY2020Q4	vuzi	Finite Lived License Agreements Noncurrent FiniteLivedLicenseAgreementsNoncurrent	193687
CY2021Q4	vuzi	Finite Lived Intangible Assets Excluding Goodwill Net FiniteLivedIntangibleAssetsExcludingGoodwillNet	147548
CY2020Q4	vuzi	Finite Lived Intangible Assets Excluding Goodwill Net FiniteLivedIntangibleAssetsExcludingGoodwillNet	566456
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1483589
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	708333
CY2021Q4	us-gaap	Assets Assets	148467057
CY2020Q4	us-gaap	Assets Assets	52471484
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2054762
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1517155
CY2021Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	27797
CY2020Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	41152
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1419308
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	983033
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	120242
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	109653
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	534146
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	444495
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4156255
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3095488
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	582876
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1072811
CY2021Q4	us-gaap	Liabilities Liabilities	4739131
CY2020Q4	us-gaap	Liabilities Liabilities	4168299
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	49626
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	50
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63672268
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45645166
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	63672
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	45645
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	346736397
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	210952473
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203072143
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-162694983
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	143727926
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	48303185
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148467057
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52471484
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	30456975
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1404831
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000007
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1145000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26476370
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	24240443
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2657831
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26750002
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1550666
CY2020	vuzi	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	14128527
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	29220
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-17952172
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	48303185
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	18429924
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	782277
CY2021	vuzi	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	34715728
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	97750007
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	6136420
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1144365
CY2021	vuzi	Stock Issued During Period Value Purchase Of Intangible Assets StockIssuedDuringPeriodValuePurchaseOfIntangibleAssets	1404750
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-10000000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-40377160
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	143727926
CY2021	us-gaap	Revenues Revenues	13164933
CY2020	us-gaap	Revenues Revenues	11581496
CY2019	us-gaap	Revenues Revenues	6670604
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	10714088
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	9653887
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	11078725
CY2021	us-gaap	Gross Profit GrossProfit	2450845
CY2020	us-gaap	Gross Profit GrossProfit	1927609
CY2019	us-gaap	Gross Profit GrossProfit	-4408121
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11674954
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7568074
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8900837
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6118929
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4039772
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4215611
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22502833
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6915213
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6600092
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1870459
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2458482
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2441581
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-183614
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	80163
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	73532
CY2021	us-gaap	Operating Expenses OperatingExpenses	42430952
CY2020	us-gaap	Operating Expenses OperatingExpenses	21055073
CY2019	us-gaap	Operating Expenses OperatingExpenses	22158121
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-39980107
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-19127464
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-26566242
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	53511
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	41120
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	252416
CY2021	us-gaap	Taxes Other TaxesOther	307368
CY2020	us-gaap	Taxes Other TaxesOther	103833
CY2019	us-gaap	Taxes Other TaxesOther	110269
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-143196
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-67895
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-52275
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1305900
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-397053
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1175292
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	89872
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40377160
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17952172
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26476370
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-40377160
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-17952172
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26476370
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2056150
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1931860
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40377160
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20008322
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28408230
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61125215
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38109765
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30348452
CY2021	us-gaap	Profit Loss ProfitLoss	-40377160
CY2020	us-gaap	Profit Loss ProfitLoss	-17952172
CY2019	us-gaap	Profit Loss ProfitLoss	-26476370
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1870459
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2458482
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2441581
CY2021	vuzi	Amortization Of Software Development Costs And Prepaid Licenses In Cost Of Sales Of Products AmortizationOfSoftwareDevelopmentCostsAndPrepaidLicensesInCostOfSalesOfProducts	439112
CY2020	vuzi	Amortization Of Software Development Costs And Prepaid Licenses In Cost Of Sales Of Products AmortizationOfSoftwareDevelopmentCostsAndPrepaidLicensesInCostOfSalesOfProducts	183328
CY2019	vuzi	Amortization Of Software Development Costs And Prepaid Licenses In Cost Of Sales Of Products AmortizationOfSoftwareDevelopmentCostsAndPrepaidLicensesInCostOfSalesOfProducts	100000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17302833
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1305900
CY2021	vuzi	Impairment Of Patents And Trademarks ImpairmentOfPatentsAndTrademarks	80163
CY2020	vuzi	Impairment Of Patents And Trademarks ImpairmentOfPatentsAndTrademarks	73532
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-183614
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2805842
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1498357
CY2021	vuzi	Inventory Reserve For Obsolescence InventoryReserveForObsolescence	519950
CY2020	vuzi	Inventory Reserve For Obsolescence InventoryReserveForObsolescence	1273835
CY2019	vuzi	Inventory Reserve For Obsolescence InventoryReserveForObsolescence	4572659
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	853547
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	289413
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	599577
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6571108
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1666792
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2998724
CY2021	vuzi	Increase Decrease In Manufacturing Vendor Prepayments IncreaseDecreaseInManufacturingVendorPrepayments	19019
CY2020	vuzi	Increase Decrease In Manufacturing Vendor Prepayments IncreaseDecreaseInManufacturingVendorPrepayments	242493
CY2019	vuzi	Increase Decrease In Manufacturing Vendor Prepayments IncreaseDecreaseInManufacturingVendorPrepayments	-512680
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	526825
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-156537
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-414997
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	537607
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	454370
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1605456
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	436276
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	97136
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	21819
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-152362
CY2021	vuzi	Increase Decrease In Deferred Income IncreaseDecreaseInDeferredIncome	-13355
CY2020	vuzi	Increase Decrease In Deferred Income IncreaseDecreaseInDeferredIncome	-101311
CY2019	vuzi	Increase Decrease In Deferred Income IncreaseDecreaseInDeferredIncome	-69263
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10589
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	90966
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-15361
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26980411
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13964053
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22355020
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3809268
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	496629
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1898771
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	593184
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	488884
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250304
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	450000
CY2019	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	758464
CY2019	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	250000
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	500000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4852452
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1485513
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3157539
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	34715728
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	14128527
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	782277
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	29220
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91613587
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25199336
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1144364
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18855007
CY2021	vuzi	Preferred Dividend Settlement Payment PreferredDividendSettlementPayment	10000000
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1555900
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	115967228
CY2019	vuzi	Amortized Common Stock Expense In Accrued Expenses AmortizedCommonStockExpenseInAccruedExpenses	93587
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36069508
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10606091
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17263643
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	120203873
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36069508
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10606091
CY2021	vuzi	Reclassification Of Unamortized Stock Compensation Expense Included In Prepaid Expenses And Other Assets ReclassificationOfUnamortizedStockCompensationExpenseIncludedInPrepaidExpensesAndOtherAssets	1365242
CY2020	vuzi	Reclassification Of Unamortized Stock Compensation Expense Included In Prepaid Expenses And Other Assets ReclassificationOfUnamortizedStockCompensationExpenseIncludedInPrepaidExpensesAndOtherAssets	219051
CY2019	vuzi	Reclassification Of Unamortized Stock Compensation Expense Included In Prepaid Expenses And Other Assets ReclassificationOfUnamortizedStockCompensationExpenseIncludedInPrepaidExpensesAndOtherAssets	83475
CY2021	us-gaap	Transfer To Investments TransferToInvestments	1294262
CY2020	us-gaap	Transfer To Investments TransferToInvestments	272444
CY2021	vuzi	Amortized Common Stock Expense In Accrued Expenses AmortizedCommonStockExpenseInAccruedExpenses	-1127091
CY2020	vuzi	Amortized Common Stock Expense In Accrued Expenses AmortizedCommonStockExpenseInAccruedExpenses	148011
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40912983
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18855007
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	84134365
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25463417
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6657552
CY2019Q4	vuzi	Accrued Revenue Current AccruedRevenueCurrent	0
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at year-end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Customer and Supplier Concentrations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">One customer represented 10% of total product revenue and four customers represented 39%, 28%, 16% and 12%, respectively, of our engineering services revenue for the year ended December 31, 2021. No one customer represented more than 10% of total product revenue and two customers represented 48% and 26%, respectively, of our engineering services revenue for the year ended December 31, 2020. One customer represented 16% of total product revenue and one customer represented 100% of engineering services revenue for the year ended December 31, 2019</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Three customers represented 27%, 20% and 10%, respectively, of accounts receivable at December 31, 2021. Two customers represented 21% and 14%, respectively, of accounts receivable at December 31, 2020. Three customers represented 32%, 26% and 13%, respectively, of accounts receivable at December 31, 2019.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Two third-party vendors represented 38% and 24%, respectively, of material purchases for the year ended December 31, 2021. As of December 31, 2021, the net amount due to these vendors was $504,073.</p>
CY2021	vuzi	Number Of Third Party Vendors NumberOfThirdPartyVendors	2
CY2020Q4	vuzi	Accrued Revenue Current AccruedRevenueCurrent	0
CY2021Q4	vuzi	Accrued Revenue Current AccruedRevenueCurrent	0
CY2021	vuzi	Unearned Revenue UnearnedRevenue	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Unearned Revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These amounts represent deferred revenue against our expected product sales returns for all December 2021 products sales that are subject to the Company’s 30-day money back guarantee return policy.</p>
CY2019	us-gaap	Advertising Expense AdvertisingExpense	1302120
CY2019	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	80163
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	73532
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-183614
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1263897
CY2020	us-gaap	Advertising Expense AdvertisingExpense	974461
CY2021	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	8,606,062
CY2021	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	8,606,062
CY2020	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	14,872,703
CY2019	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	12,858,707
CY2021	vuzi	Share Based Compensation Exclude Long Term Incentive Plan ShareBasedCompensationExcludeLongTermIncentivePlan	4047444
CY2020	vuzi	Share Based Compensation Exclude Long Term Incentive Plan ShareBasedCompensationExcludeLongTermIncentivePlan	2805842
CY2019	vuzi	Share Based Compensation Exclude Long Term Incentive Plan ShareBasedCompensationExcludeLongTermIncentivePlan	1498357
CY2021Q4	vuzi	Number Of Major Product Lines NumberOfMajorProductLines	4
CY2021	us-gaap	Revenues Revenues	13164933
CY2020	us-gaap	Revenues Revenues	11581496
CY2019	us-gaap	Revenues Revenues	6670604
CY2021	vuzi	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2021	vuzi	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	226126
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1381677
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1472534
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	11580766
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	5252709
CY2021	vuzi	Revenue Performance Obligation Percentage RevenuePerformanceObligationPercentage	1
CY2020	vuzi	Revenue Performance Obligation Percentage RevenuePerformanceObligationPercentage	1
CY2019	vuzi	Revenue Performance Obligation Percentage RevenuePerformanceObligationPercentage	1
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3352057
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1127444
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3885619
CY2021Q4	us-gaap	Inventory Net InventoryNet	12151982
CY2020Q4	us-gaap	Inventory Net InventoryNet	6100824
CY2021	vuzi	Percent Of Additional Reserve For Obsolescence On Finished Goods Inventory PercentOfAdditionalReserveForObsolescenceOnFinishedGoodsInventory	0.25
CY2021	vuzi	Net Realizable Value On Inventory Write Down NetRealizableValueOnInventoryWriteDown	519950
CY2020	vuzi	Inventory Reserve For Obsolescence InventoryReserveForObsolescence	1273835
CY2019	vuzi	Inventory Reserve For Obsolescence InventoryReserveForObsolescence	4572659
CY2020	vuzi	Effective Income Tax Rate Reconciliation Forgiveness Of Ppp Loan EffectiveIncomeTaxRateReconciliationForgivenessOfPppLoan	0.018
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11051777
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9201894
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5861339
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6364492
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5190438
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2837402
CY2021	us-gaap	Depreciation Depreciation	1306479
CY2020	us-gaap	Depreciation Depreciation	1904282
CY2019	us-gaap	Depreciation Depreciation	1913409
CY2021Q4	vuzi	Private Corporation Assets Non Current PrivateCorporationAssetsNonCurrent	450000
CY2020Q4	vuzi	Private Corporation Assets Non Current PrivateCorporationAssetsNonCurrent	250000
CY2021Q4	vuzi	Unamortized Stock Issuance Expense UnamortizedStockIssuanceExpense	491923
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1483589
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	708333
CY2019	vuzi	Effective Income Tax Rate Permanent Difference EffectiveIncomeTaxRatePermanentDifference	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.003
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	185044
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-40377160
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	683044
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	582924
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	551220
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	187323
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	185044
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	143898
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	68888
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1419308
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	983033
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	218047
CY2019	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	204583
CY2019	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	85429
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	98893
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	193503
CY2020	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	238508
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	143898
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	342392
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	383538
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-17952172
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-26476370
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8924947
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3897293
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5382746
CY2021	vuzi	Current Federal Income Tax Valuation Allowance CurrentFederalIncomeTaxValuationAllowance	-8924947
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.003
CY2020	vuzi	Effective Income Tax Rate Permanent Difference EffectiveIncomeTaxRatePermanentDifference	-0.004
CY2020	vuzi	Current State Income Tax Valuation Allowance CurrentStateIncomeTaxValuationAllowance	-94324
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016
CY2020	vuzi	Current Federal Income Tax Valuation Allowance CurrentFederalIncomeTaxValuationAllowance	-3897293
CY2019	vuzi	Current Federal Income Tax Valuation Allowance CurrentFederalIncomeTaxValuationAllowance	-5382746
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-341181
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	7916
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-511672
CY2021	vuzi	Current Foreign Income Tax Valuation Allowance CurrentForeignIncomeTaxValuationAllowance	-341181
CY2020	vuzi	Current Foreign Income Tax Valuation Allowance CurrentForeignIncomeTaxValuationAllowance	7916
CY2019	vuzi	Current Foreign Income Tax Valuation Allowance CurrentForeignIncomeTaxValuationAllowance	-511672
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-636401
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-94324
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-189200
CY2021	vuzi	Current State Income Tax Valuation Allowance CurrentStateIncomeTaxValuationAllowance	-636401
CY2019	vuzi	Current State Income Tax Valuation Allowance CurrentStateIncomeTaxValuationAllowance	-189200
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.011
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.015
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.021
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.006
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.019
CY2021	vuzi	Effective Income Tax Rate Reconciliation Expiration Of Nol Credits Charitable Contribution Percent EffectiveIncomeTaxRateReconciliationExpirationOfNolCreditsCharitableContributionPercent	-0.007
CY2020	vuzi	Effective Income Tax Rate Reconciliation Expiration Of Nol Credits Charitable Contribution Percent EffectiveIncomeTaxRateReconciliationExpirationOfNolCreditsCharitableContributionPercent	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.005
CY2021	vuzi	Effective Tax Rate EffectiveTaxRate	0.245
CY2020	vuzi	Effective Tax Rate EffectiveTaxRate	0.222
CY2019	vuzi	Effective Tax Rate EffectiveTaxRate	0.230
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.245
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.222
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.230
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36705377
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29264829
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25678591
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3924660
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3778001
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3535863
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	290713
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	847441
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	982160
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2989427
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	208803
CY2021Q4	vuzi	Deferred Tax Assets Lease Obligation Liability DeferredTaxAssetsLeaseObligationLiability	240741
CY2020Q4	vuzi	Deferred Tax Assets Lease Obligation Liability DeferredTaxAssetsLeaseObligationLiability	323186
CY2019Q4	vuzi	Deferred Tax Assets Lease Obligation Liability DeferredTaxAssetsLeaseObligationLiability	446488
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	425737
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	368243
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	263348
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	44576655
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	34790503
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	30906450
CY2020Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	10727
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	240741
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	323186
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	446488
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4057
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	27262
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	14335
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	244798
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	5479454
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	361175
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	460823
CY2021Q4	vuzi	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	-44331857
CY2020Q4	vuzi	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	-34429328
CY2019Q4	vuzi	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	-30445627
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	44331857
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34429328
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30445627
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63672268
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45645166
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	20.50
CY2021Q1	vuzi	Proceeds From Issuance Or Sale Of Equity Gross ProceedsFromIssuanceOrSaleOfEquityGross	97750007
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4768293
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	91613587
CY2019	vuzi	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	1200000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1069639
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2233062
CY2021	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	7276928
CY2020	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	2882647
CY2020	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	3647059
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7276928
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6512516
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7276928
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6512516
CY2021	vuzi	Class Of Warrant Exercised In Cash Basis ClassOfWarrantExercisedInCashBasis	7276928
CY2021	vuzi	Stock Issued During Period Shares Warrant Exercised StockIssuedDuringPeriodSharesWarrantExercised	7276928
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	34715728
CY2020	vuzi	Class Of Warrant Exercised In Cash Basis ClassOfWarrantExercisedInCashBasis	2882647
CY2020	vuzi	Stock Issued During Period Shares Warrant Exercised StockIssuedDuringPeriodSharesWarrantExercised	2882647
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	14128527
CY2019	vuzi	Stock Issued During Period Shares Warrant Exercised StockIssuedDuringPeriodSharesWarrantExercised	0
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1383591
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5329309
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6712900
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2633175
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	6583033
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	9216208
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11184450
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1550004
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	12734454
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.70
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M29D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13697906
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	869177
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	493500
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9314887
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16444695
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1753995
CY2021	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	9.62
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y9M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1251241
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.17
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M29D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1381934
CY2020	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	2.16
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P9Y3M18D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1015019
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.63
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	368572
CY2019	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.17
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y6M
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1100500
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1481000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	73500
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.40
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.08
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.71
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	13642976
CY2020	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	1602267
CY2019	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	125814
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	9355603
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1753995
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y2M12D
CY2021	vuzi	Share Based Compensation Exclude Long Term Incentive Plan ShareBasedCompensationExcludeLongTermIncentivePlan	4047444
CY2020	vuzi	Share Based Compensation Exclude Long Term Incentive Plan ShareBasedCompensationExcludeLongTermIncentivePlan	2805842
CY2019	vuzi	Share Based Compensation Exclude Long Term Incentive Plan ShareBasedCompensationExcludeLongTermIncentivePlan	1498357
CY2021Q3	us-gaap	Revenues Revenues	3019000
CY2021Q2	us-gaap	Revenues Revenues	2917000
CY2021Q1	us-gaap	Revenues Revenues	3915000
CY2021Q4	us-gaap	Gross Profit GrossProfit	209000
CY2021	vuzi	Equity Market And Operational Milestone Options Available EquityMarketAndOperationalMilestoneOptionsAvailable	5409000
CY2021Q3	us-gaap	Gross Profit GrossProfit	583000
CY2021	vuzi	Percentage Of Weightage For Equity Market Capitalization Threshold PercentageOfWeightageForEquityMarketCapitalizationThreshold	0.50
CY2021	vuzi	Percentage Of Weightage For Last Twelve Months Revenue Target PercentageOfWeightageForLastTwelveMonthsRevenueTarget	0.35
CY2021	vuzi	Percentage Of Weightage For Last Twelve Months Ebitd Margin Before Non Cash Charges Target PercentageOfWeightageForLastTwelveMonthsEBITDMarginBeforeNonCashChargesTarget	0.15
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2021	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	true
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P3Y
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	630085
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	559975
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	572767
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	559916
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	546916
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	45576
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1152408
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	35386
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1117022
CY2021Q2	us-gaap	Gross Profit GrossProfit	579000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	148131
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	142414
CY2018Q3	vuzi	Percentage Of Employee Deferrals PercentageOfEmployeeDeferrals	1
CY2021Q1	us-gaap	Gross Profit GrossProfit	1080000
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.03
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	280660
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2021Q4	us-gaap	Revenues Revenues	3314000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-11494000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-10487000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-9245000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-9151000
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11494000
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10487000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9245000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9151000
CY2020Q4	us-gaap	Revenues Revenues	4233000
CY2020Q3	us-gaap	Revenues Revenues	2779000
CY2020Q2	us-gaap	Revenues Revenues	3037000
CY2020Q1	us-gaap	Revenues Revenues	1532000
CY2020Q4	us-gaap	Gross Profit GrossProfit	703000
CY2020Q3	us-gaap	Gross Profit GrossProfit	348000
CY2020Q2	us-gaap	Gross Profit GrossProfit	796000
CY2020Q1	us-gaap	Gross Profit GrossProfit	81000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-3590000
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10081000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5967000
CY2019Q3	us-gaap	Revenues Revenues	1159000
CY2019Q2	us-gaap	Revenues Revenues	2186000
CY2019Q1	us-gaap	Revenues Revenues	1373000
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2019Q4	us-gaap	Revenues Revenues	1953000
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5534000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6826000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4761000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-4239000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-5362000
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4120000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5281000
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4746000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5861000
CY2019Q4	us-gaap	Gross Profit GrossProfit	-4369000
CY2019Q3	us-gaap	Gross Profit GrossProfit	-231000
CY2019Q2	us-gaap	Gross Profit GrossProfit	152000
CY2019Q1	us-gaap	Gross Profit GrossProfit	40000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-9583000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-5477000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-5056000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-6360000
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	371000
CY2019	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	4566000
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-149000
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4788000
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4788000
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	1274000
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-2176000
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3886000
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3886000
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	520000
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-3279000
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1127000

Files In Submission

Name	View Source	Status
0001558370-22-002641-index-headers.html	Edgar Link	pending
0001558370-22-002641-index.html	Edgar Link	pending
0001558370-22-002641.txt	Edgar Link	pending
0001558370-22-002641-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vuzi-20211231.xsd	Edgar Link	pending
vuzi-20211231x10k.htm	Edgar Link	pending
vuzi-20211231x10k001.jpg	Edgar Link	pending
vuzi-20211231x10k_htm.xml	Edgar Link	completed
vuzi-20211231xex23d1.htm	Edgar Link	pending
vuzi-20211231xex31d1.htm	Edgar Link	pending
vuzi-20211231xex31d2.htm	Edgar Link	pending
vuzi-20211231xex32d1.htm	Edgar Link	pending
vuzi-20211231xex32d2.htm	Edgar Link	pending
vuzi-20211231_cal.xml	Edgar Link	unprocessable
vuzi-20211231_def.xml	Edgar Link	unprocessable
vuzi-20211231_lab.xml	Edgar Link	unprocessable
vuzi-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VUZI
Vuzix Corp Stock $vuzi

2021 Q4 Form 10-K Financial Statement

#000155837022002641 Filed on March 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI Vuzix Corp Stock $vuzi

2021 Q4 Form 10-K Financial Statement

#000155837022002641 Filed on March 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI
Vuzix Corp Stock $vuzi